(Q34359068)

1 August 2017

title

The effects of age on the pharmacokinetics, antihypertensive efficacy and general tolerability of dilevalol (English)

1 reference

1 August 2017

1 reference

Macphee GJ

1

1 reference

1 August 2017

Howie CA

series ordinal

2

1 reference

1 August 2017

Meredith PA

series ordinal

3

1 reference

1 August 2017

Elliott HL

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 November 1991

1 reference

British Journal of Clinical Pharmacology

1 August 2017

published in

1 reference

1 August 2017

volume

32

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

591-597

1 reference

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

The effects of enzyme induction and enzyme inhibition on labetalol pharmacokinetics

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 years. Report from a double-blind international multicenter study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

Initial blood pressure as a predictor of the response to antihypertensive therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

Pharmacokinetics of dilevalol in normotensive and hypertensive volunteers.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

Hemodynamic effects of beta-blocking compounds possessing vasodilating activity: a review of labetalol, prizidilol, and dilevalol

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

Dilevalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

Plasma metoprolol concentrations in young, old and hypertensive subjects

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

The effect of ageing on the hepatic clearance of propranolol

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

Antihypertensive beta blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

Reduced β-adrenoceptor sensitivity in the elderly

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368636

Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1991.TB03957.X

Hemodynamic and humoral effects of intravenous dilevalol in patients with moderate hypertension

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1991.TB03957.X

Hemodynamic Effects of β-Blocking Compounds Possessing Vasodilating Activity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1991.TB03957.X

Age and beta adrenoceptor–mediated function

21 January 2018

1 reference

12 December 2020

Atenolol versus bendroflumethiazide in middle-aged and elderly hypertensives

1 reference

12 December 2020

High-performance liquid chromatographic assay for dilevalol in human plasma and urine using a PRP-1 column and fluorimetric detection

1 reference

12 December 2020

Nifedipine: individual responses and concentration-effect relationships

1 reference

12 December 2020

Pharmacokinetics and bioavailability of dilevalol in normotensive volunteers

1 reference

12 December 2020

Clinical pharmacology of dilevalol (II). The pharmacokinetic, pharmacodynamic, and tolerance studies of dilevalol during repeated administration in healthy subjects

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of dilevalol

1 reference

12 December 2020

10.1111/J.1365-2125.1991.TB03957.X

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference